Chemical Diversity: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
| predecessor = |
| predecessor = |
||
| successor = |
| successor = |
||
| foundation = {{ |
| foundation = <!-- {{Start date|YYYY|MM|DD}} -->1990 |
||
| founder = |
| founder = |
||
| defunct = |
| defunct = |
||
| |
| location_city = San Diego, CA |
||
| location_country = USA |
|||
| location = |
|||
| locations = |
| locations = |
||
| area_served = |
| area_served = |
||
| key_people = |
| key_people = |
||
| industry = |
| industry = |
||
| products = |
| products = |
||
| services = |
|||
| services = clinical development, pre-clinical development, drug discovery, discovery tools, chemistry |
|||
| revenue = |
| revenue = |
||
| operating_income = |
| operating_income = |
||
| Line 26: | Line 28: | ||
| equity = |
| equity = |
||
| owner = |
| owner = |
||
| num_employees = |
| num_employees = |
||
| parent = |
| parent = |
||
| divisions = |
| divisions = |
||
| subsid = |
| subsid = |
||
| homepage = <!-- {{URL|example.com}} --> |
| homepage = <!-- {{URL|example.com}} --> |
||
| footnotes = |
| footnotes = |
||
| intl = |
| intl = |
||
Revision as of 21:45, 3 March 2011
| Company type | Private |
|---|---|
| Founded | 1990 |
| Headquarters | San Diego, CA , USA |
Chemical Diversity (ChemDiv) is a fully integrated Contract research organization/CRO headquartered in San Diego, California/CA, with subsidiaries in Russia and Ukraine. It provides pharmaceutical and biotech companies integrated discovery and development solutions for their R&D programs. ChemDiv's services cover a range of disciplines needed to bring a new project in CNS, oncology, inflammation, metabolism/metabolic, Infectious disease/infectious and other diseases from identification of a biological target (protein expression, assay development etc.) to clinical drug candidates (ADME/DMPK, toxicity and safety studies, efficacy models etc.) to Proof of Concept drug candidate (Phase I and II) and to the market.
ChemDiv started in 1990 as a chemistry provider and has moved to a full service Contract research organization/CRO since. Among its partners are Eli Lilly[1], Novartis[2][3], Dendreon[4], Merck KGaA[5], Solvay Pharmaceutical/Solvay Pharmaceuticals[6], Bayer, etc.
References
- ^ "ChemDiv-Lilly Collaboration Expanded to Include New Discovery Program", Fierce Biotech, August 20, 2009
- ^ "Chemical Diversity Research Institute Of Chemrar Announces Starting Of Discovery Collaboration With The Largest Major Pharmaceutical Company On The Russian Market", October 18, 2010
- ^ "ChemDiv and ChemRar Hi-Tech Center join forces with Singapore and Switzerland in battling Tuberculosis", October 13, 2010
- ^ "ChemDiv - Dendreon Partnership" , Case Study
- ^ "ChemDiv to Provide Merck KGaA With Discovery Chemistry in Multiyear Agreement, Extending Ongoing Collaboration" , Drugs.com, February 13, 2007
- ^ "Solvay Pharmaceuticals, Inc. Signs Collaboration Agreement With ChemDiv, Inc. For Early Discovery Activities" , BioSpace, February 10, 2009
External links
- "www.chemdiv.com" Company's website
- "eshop.chemistryondemand.com" Company's commercial portal